Skip to main content
. Author manuscript; available in PMC: 2014 Dec 2.
Published in final edited form as: Transl Res. 2014 Jun 17;164(5):424–432. doi: 10.1016/j.trsl.2014.06.003

Fig 5.

Fig 5

Angiotensin II antagonism prevents an increase in CSA in diabetes. A. CSA across the pressure range is increased in diabetic GK rats and azilsartan medoxomil treatment lowers CSA in diabetes (*p<0.05 vs other groups). B. CSA at 100 mmHg pressure point is greater in GK rats (*p<0.05 vs Wis) and treatment reduces it diabetic animals (#p<0.05 vs vehicle). C. β-coefficient was greater in diabetic animals indicating stiffer vessels (*p<0.05 vs Wis, #p<0.05 vs vehicle, **p=0.016; disease and treatment interaction). Values are mean ± SEM, n=6–11/group.